![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/08\/4395-logoo20Else20Nutrition.jpg\")
<\/p>\n<\/p>\n
Capability Opens Up Major Growth Pathways including the $1 Billion U.S. Kids Nutrition Drinks Market, and the massive, $4 Billion, U.S. Infant formula Market upon FDA approval.<\/em>\u00a0<\/em><\/p>\n VANCOUVER, BC, August 4, 2021 – ELSE NUTRITION HOLDINGS INC. (<\/strong>BABY.V<\/strong><\/a>) (<\/strong>BABYF<\/strong><\/a>) (<\/strong>0YL.F<\/strong><\/a>) (“Else” <\/strong>or the “Company”)<\/strong> the plant-based baby, toddler and children nutrition company<\/a>, announces that after months of R&D and trials, it has successfully completed a\u00a0 full-scale commercial trial\u00a0 manufacturing run of ready to drink (RTD) liquid version of its Plant-Based Complete Nutrition for Toddlers and Kids products.<\/p>\n \u201cThis key milestone sets the Company on a path to penetrate the lucrative liquid format in both the Toddler and Kids Nutrition space,\u201d said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. \u201cWith thousands of families nationwide already using Else products in powder format, being able to offer Clean Label, whole food-based Else products in convenient RTD form, opens up a further 92% of the Kids nutritional drinks market, a $1 billion category in the U.S. alone.\u201d she added.<\/p>\n Else intends to further use this capability to drive growth in the Kids and Toddler RTD markets across many geographies and sets the stage for being able to offer its planned infant formula in liquid format, upon receipt of FDA approval. The capacity to offer Else products in liquid format further enables the brand to penetrate hospitals with a long-awaited, Plant-Based liquid formula alternative, therein creating a critical competitive advantage for the Else brand. The hospital channel is of paramount importance in a parent\/caregivers\u2019 decision-making process when it comes choosing a formula for their baby\/child.\u00a0<\/strong><\/p>\n About Else Nutrition Holdings Inc.<\/strong><\/p>\n Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives include leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics, and leading infant nutrition Societies,\u00a0 and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.<\/p>\n For more information, visit:\u00a0elsenutrition.com<\/a>\u00a0or @elsenutrition on Facebook and Instagram.<\/p>\n <\/p>\n Media Contact<\/strong><\/p>\n Erin Jundef <\/p>\n For more information, contact:<\/strong><\/p>\n Mrs. Hamutal Yitzhak, CEO, Co-Founder & Director <\/p>\n US Investor Relations Contact <\/p>\n TSX Venture Exchange<\/em><\/strong>\u00a0<\/em><\/strong><\/p>\n Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/em>\u00a0<\/em><\/p>\n Caution Regarding Forward-Looking Statements<\/em><\/strong>\u00a0<\/em><\/strong><\/p>\n This press release contains statements that may constitute \u201cforward-looking statements\u201d within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as \u201cwill\u201d or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company\u2019s financial disclosure documents.\u00a0 Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management\u2019s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. \u00a0Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.\u00a0 Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management\u2019s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.<\/em><\/p>\n Tags: Nutrition<\/a>, nutrition company<\/a>, nutrition for children<\/a>, plant based nutrition<\/a>, nutrition for toddlers.<\/a>, elsenutrition<\/a>, Kids Nutrition Products<\/a> <\/p>\n The post Else Nutrition Completes Successful Commercial Trial Manufacturing Run of Ready to Drink Plant-Based Toddler & Kids Nutrition Products<\/a> appeared first on Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" Capability Opens Up Major Growth Pathways including the $1 Billion U.S. Kids Nutrition Drinks Market, and the massive, $4 Billion, U.S. Infant formula Market upon FDA approval. VANCOUVER, BC, August 4, 2021 – ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company, announces that after […]<\/p>\n The post Else Nutrition Completes Successful Commercial Trial Manufacturing Run of Ready to Drink Plant-Based Toddler & Kids Nutrition Products<\/a> appeared first on Financial Market Brief<\/a>.<\/p>\n
\nBrilliant PR
\nerinj@brilliantpr.com<\/a><\/p>\n
\nELSE Nutrition Holdings Inc.
\nE: hamutaly@elsenutrition.com<\/a>
\nP: +972(0)3-6445095
\nMr. Sokhie Puar, Director of Else Nutrition
\nE:\u00a0 sokhiep@elsenutrition.com<\/a>
\nP:\u00a0 604-603-7787<\/p>\n
\n<\/strong>Lytham Partners, LLC
\nMr. Ben Shamsian
\nNew York | Phoenix
\nE: shamsian@lythampartners.com<\/a>
\nP: 646-829-9701<\/p>\nSee Campaign: <\/strong>http:\/\/www.elsenutrition.com\/<\/a>
Tags:<\/b>
<\/a>, Menafn<\/a>, IPS<\/a>, Reportedtimes<\/a>, Google News<\/a>, Financial Content<\/a>, ReleaseLive<\/a>, PR-Wirein<\/a>, Extended Distribution<\/a>, iCN Internal Distribution<\/a>, English<\/a><\/p>\n<\/div>\n